**Core Concept**
Alkaptonuria is a rare genetic disorder characterized by the accumulation of homogentisic acid in the body due to a defect in the breakdown of the amino acids tyrosine and phenylalanine. The disorder leads to the production of dark urine, ochronosis (pigmentation of connective tissue), and other systemic complications.

**Why the Correct Answer is Right**
The correct answer is related to the enzyme homogentisate 1,2-dioxygenase (HGD), which catalyzes the conversion of homogentisic acid to maleylacetoacetate in the tyrosine catabolic pathway. In alkaptonuria, mutations in the HGD gene result in a deficiency of this enzyme, leading to the accumulation of homogentisic acid and its subsequent metabolites.

**Why Each Wrong Option is Incorrect**
**Option A:** Phenylalanine hydroxylase - This enzyme is involved in the conversion of phenylalanine to tyrosine, which is not directly related to the pathophysiology of alkaptonuria.

**Option B:** Tyrosine aminotransferase - This enzyme is involved in the metabolism of tyrosine, but it is not the enzyme deficient in alkaptonuria.

**Option C:** Aldehyde dehydrogenase - This enzyme is involved in the metabolism of various aldehydes, but it is not directly related to the pathophysiology of alkaptonuria.

**Option D:** Alanine transaminase - This enzyme is involved in the metabolism of amino acids, but it is not the enzyme deficient in alkaptonuria.

**Clinical Pearl / High-Yield Fact**
Alkaptonuria is an autosomal recessive disorder, and patients often present with dark urine, ochronotic pigmentation, and joint degeneration. The diagnosis is made by detecting homogentisic acid in the urine and confirming the deficiency of homogentisate 1,2-dioxygenase enzyme.

**Correct Answer:** C.